BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16404424)

  • 1. Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.
    Bojesen SE; Ammerpohl O; Weinhäusl A; Haas OA; Mettal H; Bohle RM; Borkhardt A; Fuchs U
    Br J Cancer; 2006 Jan; 94(2):323-32. PubMed ID: 16404424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.
    Qian Z; Qian J; Lin J; Yao DM; Chen Q; Ji RB; Li Y; Xiao GF; Li JY
    J Exp Clin Cancer Res; 2010 Aug; 29(1):111. PubMed ID: 20704716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.
    Qian J; Qian Z; Lin J; Yao DM; Chen Q; Li Y; Ji RB; Yang J; Xiao GF; Wang YL
    Leuk Res; 2011 Jun; 35(6):783-6. PubMed ID: 21074269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
    Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
    [No Abstract]   [Full Text] [Related]  

  • 5. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Flotho C; Paulun A; Batz C; Niemeyer CM
    Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
    Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
    Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations.
    Au WY; Fung A; Man C; Ma SK; Wan TS; Liang R; Kwong YL
    Br J Haematol; 2003 Mar; 120(6):1062-5. PubMed ID: 12648079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
    Mori N; Yoshinaga K; Tomita K; Ohwashi M; Kondoh T; Shimura H; Wang YH; Shiseki M; Okada M; Motoji T
    Leuk Res; 2011 Apr; 35(4):516-21. PubMed ID: 20828818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
    Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes.
    Tsukamoto N; Morita K; Karasawa M; Omine M
    Exp Hematol; 1992 Oct; 20(9):1061-4. PubMed ID: 1468540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
    Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
    Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.
    Pigazzi M; Manara E; Bresolin S; Tregnago C; Beghin A; Baron E; Giarin E; Cho EC; Masetti R; Rao DS; Sakamoto KM; Basso G
    Haematologica; 2013 Apr; 98(4):602-10. PubMed ID: 23100280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
    Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
    Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
    Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
    Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia.
    Brakensiek K; Wingen LU; Länger F; Kreipe H; Lehmann U
    Clin Chem; 2007 Jan; 53(1):17-23. PubMed ID: 17095538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.